Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- JBHT -7.1%, ASML -4.8%, USB -3.7%, FULT -2.7%, TRV -2.6%, IBKR -1.1%
Other news:
- SAGE -19.8% (topline results from phase 2 precedent study of dalzanemdor)
- ADSK -4.6% (provides update on delayed 10-K filing; currently does not believe matters under investigation affect any previously issued financial statements)
- APG -4% (prices offering of 11.0 mln shares of common stock at $37.50 per share)
- MEG -2.3% (3 mln share offering)
- ACRV -1.9% (to Host Corporate R&D Event Highlighting AP3 and Pipeline Progress, Including Ongoing Prospective Validation of ACR-368 OncoSignature with Initial Phase 2 Data for ACR-368, and Preclinical Progress for ACR-2316)
- ITCI -1.1% (commences $500 mln stock offering; also files mixed shelf securities offering)